PP_1170x120_10-25-21

Dipankar Bhattacharjee

Teva unveils reorganization plan

Teva unveils reorganization plan

  JERUSALEM, Israel — Just over two months after naming a new chief executive officer, Teva Pharmaceutical Industries Ltd., the world’s largest maker of generic drugs, is reorganizing its business and leadership structure. Teva said Monday that it’s integrating its drug businesses into one commercial organization, and there will no longer be two separate global

Teva launches generic version of Zetia

Teva launches generic version of Zetia

JERUSALEM, Israel — Teva Pharmaceutical Industries Ltd. has released ezetimibe tablets 10 mg, a cholesterol-lowering medication, in the United States. Teva said its ezetimibe product is a generic version of Zetia tablets from Merck & Co. Ezetimibe tablets work to reduce the amount of cholesterol the body absorbs. The drug is used to lower levels

Teva announces CEO succession for generics group

Teva announces CEO succession for generics group

JERUSALEM, Israel — Dipankar Bhattacharjee has been promoted to president and chief executive officer of the Global Generic Medicines Group at Teva Pharmaceutical Industries Ltd. The appointment is effective immediately. Bhattacharjee, who has served as president and CEO of Teva Generics Europe since April 2013, succeeds Sigurdur Olafsson, who will step down from his role